Conditions: Hepatitis C Virus Infection
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 107
Healthy volunteers: no

Brief summary:
The primary objectives of this study are to evaluate the efficacy, safety and tolerability of treatment with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in participants with chronic HCV infection who were coinfected with HIV-1.

Detailed description:

Arms:
arm 1: Participants will receive SOF/VEL for 12 weeks

Interventions: intervention 1: SOF/VEL
Intervention descriptions: intervention 1: 400/100 mg fixed-dose combination (FDC) tablet administered orally once daily

Protocol document: